Evidence map›Paper›PMID 39116349›Full record

ArticleAmerican journal of physiology. Renal physiology2024

VCAM-1 mediates proximal tubule-immune cell cross talk in failed tubule recovery during AKI-to-CKD transition.

Isabel Melchinger, Kailin Guo, Xiaoxu Li, Jiankan Guo, Lloyd G Cantley, Leyuan Xu

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. The GPX3-VCAM1 Axis Gates Pro-Fibrotic Tubule Cell Fate in Hyperuricemic Nephropathy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Isabel MelchingerSection of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States.
Kailin GuoSection of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States.
Xiaoxu LiSection of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States.
Jiankan GuoSection of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States.ORCID 0000-0001-8379-7091
Lloyd G CantleySection of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States.
Leyuan XuSection of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States.ORCID 0000-0002-3071-9206

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Macrophage Function in Kidney RepairR01DK093771 · NIDDK · YALE UNIVERSITY · PI LLOYD G CANTLEY · 2012 to 2026
$3.9M
Targeting immune dysfunction during transition from AKI to CKDR01DK135689 · NIDDK · YALE UNIVERSITY · PI Leyuan Xu · 2023 to 2026
$1.5M
Targeting macrophage persistence to prevent the AKI-to-CKD transitionK01DK120783 · NIDDK · YALE UNIVERSITY · PI XU, LEYUAN · 2019 to 2023
$698k
NCATS NIH HHS UL1 TR001863NIDDK NIH HHS K01 DK120783NIDDK NIH HHS R01 DK093771NIDDK NIH HHS R01 DK135689
6 · The paper itself

Abstract

Studies in animal models have suggested a linkage between the inflammatory response to injury and subsequent nephron loss during the acute kidney injury (AKI) to chronic kidney disease (CKD) transition. Failure of normal repair during the CKD transition correlates with de novo expression of vascular cell adhesion protein-1 (VCAM-1) by a subset of injured proximal tubule cells. This study identified the role of VCAM-1 expression in promoting the failed repair state. Single-cell transcriptome analysis of patients with AKI and CKD and whole kidney RNA and protein analyses of mouse models of CKD confirmed a marked increase of VCAM-1 expression in the proximal tubules of injured kidneys. In immortalized mouse proximal tubular cells and primary cultured renal cells (PCRCs), VCAM-1 expression was induced by proinflammatory cytokines including tumor necrosis factor (TNF)-α and interleukin (IL)-1β. Analyses of bulk RNA sequencing of TNF-α-treated primary cultured renal cells or pseudo-bulk RNA sequencing of biopsies from Kidney Precision Medicine Project datasets indicated activation of NF-κB and an enrichment of inflammatory response and cell adhesion pathways in VCAM-1-positive cells. Pharmacological inhibition of NF-κB signaling or genetic deletion of myeloid differentiation factor 88 and TIR domain-containing adapter-inducing interferon-β suppressed TNF-α- and IL-1β-induced VCAM-1 expression in vitro. TNF-α stimulation or overexpression of VCAM-1 significantly increased splenocyte adhesion to the mouse proximal tubular monolayer in culture. These results demonstrate that persistence of proinflammatory cytokines after AKI can induce NF-κB-dependent VCAM-1 expression by proximal tubule cells, mediating increased immune cell adhesion to the tubule and thus promoting further tubule injury and greater risk of progression from AKI to CKD.

Indexed as

Acute Kidney InjuryKidney Tubules, ProximalRenal Insufficiency, ChronicVascular Cell Adhesion Molecule-1AnimalsCell AdhesionDisease Models, AnimalDisease ProgressionHumansMaleMiceMice, Inbred C57BLNF-kappa BSignal TransductionNF-kappa BVascular Cell Adhesion Molecule-1acute kidney injurychronic kidney diseaseimmune cellinflammationVCAM-1

Identifiers

PMID39116349
PMCPMC11483080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.